Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
A 16.84 0.84% 0.14
HOOK closed up 0.84 percent on Thursday, May 13, 2021, on 1.35 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical HOOK trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Earnings Movers Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Older End-of-Day Signals for HOOK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 15 hours ago
Possible Inside Day about 15 hours ago
Down 3% about 16 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Down 2 % about 17 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


HOOKIPA Pharma Inc. Description

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Cancers Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Gilead Sciences Papillomavirus Immunotherapeutics Kidney Transplant

Is HOOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.7502
52 Week Low 8.12
Average Volume 211,880
200-Day Moving Average 11.40
50-Day Moving Average 13.29
20-Day Moving Average 13.71
10-Day Moving Average 15.09
Average True Range 1.00
ADX 27.6
+DI 31.40
-DI 9.67
Chandelier Exit (Long, 3 ATRs ) 14.75
Chandelier Exit (Short, 3 ATRs ) 14.60
Upper Bollinger Band 16.90
Lower Bollinger Band 10.52
Percent B (%b) 0.99
BandWidth 46.56
MACD Line 0.93
MACD Signal Line 0.53
MACD Histogram 0.4003
Fundamentals Value
Market Cap 367.97 Million
Num Shares 21.9 Million
EPS -4.91
Price-to-Earnings (P/E) Ratio -3.43
Price-to-Sales 15.72
Price-to-Book 3.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.15
Resistance 3 (R3) 19.16 18.41 18.76
Resistance 2 (R2) 18.41 17.82 18.40 18.64
Resistance 1 (R1) 17.62 17.45 18.01 17.61 18.51
Pivot Point 16.87 16.87 17.06 16.86 16.87
Support 1 (S1) 16.08 16.28 16.48 16.07 15.17
Support 2 (S2) 15.33 15.91 15.32 15.04
Support 3 (S3) 14.54 15.33 14.92
Support 4 (S4) 14.53